You Searched For "SII coronavirus vaccine" and got 20 results
Sort By:
Serum’s Covishield vaccine gets expert panel recommendation, paving the way for first authorized COVID-19 shot in India
An expert panel of India's drug regulator on Friday recommended emergency use approval for Oxford-A…
Serum Institute of India to produce 100 million doses of COVID-19 vaccine for less than ₹250 a dose
Serum Institute of India (SII), the worlds largest vaccine manufacturer by volume, has entered into…
Serum Institute may begin human trials of Oxford-AstraZeneca’s COVID-19 vaccine candidate from August 25
The trials will be held at PGIMER Chandigarh, AIIMS in Delhi, ABJ Medical College in Pune, Rajen…
Serum Institute claims that its COVID vaccine is safe and that it has a clean chit from the authorities for Covishield
The Serum Institute of India (SII) claims it has a clean chit from the authorities and that its COV…
Bharat Biotech’s Covaxin shows 81% efficacy after second dose in phase 3 trials
Hyderabad-based Bharat Biotech released phase 3 results of its Covid-19 vaccine — Covaxin — today. …
Oxford’s COVID-19 vaccine: Phase III human trials begin in India
Serum Institute is likely to conduct the Phase III trials on 1,500 volunteers across 14 locati…
Oxford-Astrazeneca COVID-19 Vaccine: Phase II trials will begin in India today
"To start with we have identified five volunteers who will undergo COVID-19 and antibodies tests…
India COVID-19 vaccine updates — Oxford's potential coronavirus vaccine reports no side affect so far in vaccine trial at PGI Chandigarh
As India records over 1 million COVID-19 deaths, scientists in India are racing against time to d…
Oxford COVID-19 vaccine may hit the Indian market by the end of the year if successful, says CEO of world’s largest vaccine manufacturer
World’s largest vaccine manufacturer, the Serum Institute of India (SSI), hopes oxford COVID-19 vac…
There are a lot of coronavirus vaccines in the works— but these are the two that Indians should watch out for
“I think the Oxford vaccine and Chinese vaccine are certainly in the more advanced clinical phas…
Serum Institute insists Covishield is the most affordable vaccine in the market today; says price has been increased so that they can invest into scaling up production
It currently charges the central government ₹150 per dose for the existing supplies. The…
PTI
Sanofi, one of the largest drug makers, will test experimental coronavirus vaccine on humans starting September
The plan is to get thousands of subjects on board across the world to test the experimental c…
India to have coronavirus vaccine by 2020 end: Harsh Vardhan
New Delhi, Aug 22 (IANS) Union Minister of Health and Family Welfare Harsh Vardhan said on Saturday…
The success story of Cyrus Poonawalla: The vaccine king who is one of the world’s richest billionaires
India’s vaccine king tried to make an affordable Jaguar but chose to go for a ‘product of the masse…
Serum Institute of India to soon apply for local trials of AstraZeneca-Oxford Covid-19 vaccine
The Serum Institute of India (SII) will soon apply to the Indian regulator for the licensure tria…
DCGI gives nod to Serum Institute of India for phase 2 and 3 human clinical trials of the Oxford COVID-19 vaccine candidate
"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the C…
PTI
India may have a COVID-19 vaccine by the 'start of next year', says Union Health Minister Harsh Vardhan
Union Health Minister Harsh Vardhan on Thursday said that the coronavirus vaccine will be made avai…
With over 30,000 new cases, India's COVID-19 tally crosses 9.8 million
With 30,006 new coronavirus infections and 442 deaths in the past 24 hours, India's overall tally s…
India largest buyer of COVID-19 vaccine with 1.6 billion doses, experts say this could cover 60% population
The 'Launch and Scale Speedometer' analysis, which is updated every two weeks, shows India has…
PTI
Coronavirus vaccine Covishield completes enrolment of phase-3 clinical trials under ICMR, Serum Institute's partnership
"The partnership is a stellar example of private-public institutes collaborating to mitigate the…